NPI: 1679757751 · RHINELANDER, WI 54501 · Clinic/Center · NPI assigned 12/24/2007
Authorized official YANG, JERRY controls 20+ related entities in our dataset. Read more
| Authorized Official | YANG, JERRY (SVP & CHIEF FINANCIAL OFFICER) |
| Parent Organization | ASPIRUS MEDICAL GROUP, INC. |
| NPI Enumeration Date | 12/24/2007 |
Other providers sharing the same authorized official: YANG, JERRY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,214 | $93K |
| 2019 | 2,745 | $79K |
| 2020 | 2,398 | $69K |
| 2021 | 3,617 | $97K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,589 | 3,269 | $151K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4,942 | 4,429 | $138K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 333 | 117 | $10K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 486 | 235 | $8K |
| 80053 | Comprehensive metabolic panel | 809 | 748 | $8K |
| 80061 | Lipid panel | 410 | 385 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 294 | 260 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 253 | 223 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 127 | 58 | $2K |
| 90686 | 138 | 131 | $1K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 187 | 174 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | 167 | 145 | $1K |
| 80050 | General health panel | 25 | 24 | $1K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13 | 12 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 15 | 15 | $763.56 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15 | 14 | $500.29 |
| 83036 | Hemoglobin; glycosylated (A1C) | 25 | 25 | $257.01 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 24 | 13 | $100.89 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 122 | 62 | $0.75 |